Cipla received approval from India's Central Drugs Standard Control Organisation to distribute and market Afrezza inhalation ...

Novo Nordisk's Lotte Bjerre Knudsen says her determination is a key part of the success, but she also stays humble.

This article reviews the published evidence over two decades of use of the NovoPen ® family of injection devices in diabetes management. A search for NovoPen ® publications from 1985 onwards was ...

Sol-Millennium® Medical Group, a leading manufacturer of medical devices, has launched an innovative needle-free injection ...

Tirzepatide Shows Powerful Diabetes-Prevention Effect in Three-Year Trial Nov. 26, 2024 — Tirzepatide, a new injectable weight-loss drug, reduced the risk of diabetes in patients with obesity ...

Including the acquisition and expansion of the manufacturing facility, Eli Lilly will be investing $4bn in the site. After ...

Recognizing and addressing these common missteps can pave the way for better diabetes management and overall well-being. ...

INDIANAPOLIS (WISH) — A recent poll found that about 15.5 million Americans have used injectable diabetes medicines like Ozempic and Wegovy to lose weight. While these drugs are becoming wildly ...

Afrezza, world’s only rapid-acting, inhaled insulin for type 1 & type 2 diabetes patients & manufactured by MannKind, ...

Eli Lilly is doubling down on manufacturing investments announcing a US3 billion expansion of its Wisconsin facility ...